Prestige Consumer Fair Value
PB
The fair market value of PBH stock is 60.04 USD. Relative to the market price of 81.63 USD Prestige Consumer is overvalued by 26.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Prestige Consumer Valuation
Current PBH share ticker price is 81.63 USD.
The fair value level of 60.04 USD can be considered as an effective entry point for long-term investors to start investing in PBH stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 26% higher its fair value
Current price is 41% higher its minimum value
Current price is 14% higher its maximum value
Market price:
PBH stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Prestige Consumer Healthcare Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
16.94
2
Median P/E over 5 years
14.47
3
Minimum P/E over 5 years
11.54
4
Earning per share (last 12 months)
4.15 USD
Maximum value
1
x
4
=
70.31 USD
Fair value
2
x
4
=
60.04 USD
Minimum value
3
x
4
=
47.88 USD
Prestige Consumer Healthcare Inc price metrics
16.36
Annual return (geometric mean)
28.3
Risk (standard deviation) of returns
β
0.47
Beta (volatility compared to market)